Biomea Fusion Stock Performance

BMEA Stock  USD 1.32  0.04  3.13%   
On a scale of 0 to 100, Biomea Fusion holds a performance score of 8. The firm shows a Beta (market volatility) of 1.41, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomea Fusion will likely underperform. Please check Biomea Fusion's jensen alpha, maximum drawdown, semi variance, as well as the relationship between the sortino ratio and potential upside , to make a quick decision on whether Biomea Fusion's price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biomea Fusion are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical and fundamental indicators, Biomea Fusion sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Acquisition by Averill Julianne of 241177 shares of Biomea Fusion at 1.82 subject to Rule 16b-3
11/26/2025
2
Acquisition by Erdtmann Rainer M of 40000 shares of Biomea Fusion at 1.1013 subject to Rule 16b-3
11/28/2025
3
Acquisition by Michael Hitchcock of 100000 shares of Biomea Fusion at 0.9918 subject to Rule 16b-3
12/02/2025
4
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes Cardiovascular Disease
12/05/2025
5
Biomea Fusion, Inc. Given Consensus Rating of Moderate Buy by Analysts
12/09/2025
6
Insider Spends US99k Buying More Shares In Biomea Fusion
12/11/2025
7
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17/2025
8
Is Biomea Fusion Inc. stock near bottom after decline - 2025 Market Outlook AI Driven Stock Reports - ulpravda.ru
01/09/2026
9
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference - TipRanks
01/14/2026
10
Biomea Fusion, Inc. Given Consensus Rating of Moderate Buy by Brokerages
01/26/2026
11
Biomea Fusion Shares Down 3 percent Heres Why
02/12/2026
12
Biomea Fusion to Participate at Upcoming Investor Conferences - marketscreener.com
02/19/2026
Begin Period Cash Flow177.2 M
Total Cashflows From Investing Activities-362 K

Biomea Fusion Relative Risk vs. Return Landscape

If you would invest  101.00  in Biomea Fusion on November 24, 2025 and sell it today you would earn a total of  31.00  from holding Biomea Fusion or generate 30.69% return on investment over 90 days. Biomea Fusion is currently generating 0.5788% in daily expected returns and assumes 5.3415% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Biomea, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Biomea Fusion is expected to generate 7.22 times more return on investment than the market. However, the company is 7.22 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Biomea Fusion Target Price Odds to finish over Current Price

The tendency of Biomea Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.32 90 days 1.32 
about 36.05
Based on a normal probability distribution, the odds of Biomea Fusion to move above the current price in 90 days from now is about 36.05 (This Biomea Fusion probability density function shows the probability of Biomea Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.41 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biomea Fusion will likely underperform. Additionally Biomea Fusion has an alpha of 0.0853, implying that it can generate a 0.0853 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Biomea Fusion Price Density   
       Price  

Predictive Modules for Biomea Fusion

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biomea Fusion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biomea Fusion's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.356.69
Details
Intrinsic
Valuation
LowRealHigh
0.132.698.03
Details
Naive
Forecast
LowNextHigh
0.031.466.80
Details
9 Analysts
Consensus
LowTargetHigh
6.377.007.77
Details

Biomea Fusion Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Biomea Fusion is not an exception. The market had few large corrections towards the Biomea Fusion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biomea Fusion, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biomea Fusion within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.09
β
Beta against Dow Jones1.41
σ
Overall volatility
0.14
Ir
Information ratio 0.02

Biomea Fusion Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biomea Fusion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biomea Fusion can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Biomea Fusion is way too risky over 90 days horizon
Biomea Fusion may become a speculative penny stock
Biomea Fusion appears to be risky and price may revert if volatility continues
Biomea Fusion has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (138.43 M) with profit before overhead, payroll, taxes, and interest of 0.
Biomea Fusion currently holds about 149.63 M in cash with (119.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Biomea Fusion has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Biomea Fusion to Participate at Upcoming Investor Conferences - marketscreener.com

Biomea Fusion Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biomea Stock often depends not only on the future outlook of the current and potential Biomea Fusion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biomea Fusion's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding36.1 M
Cash And Short Term Investments58.3 M

Biomea Fusion Fundamentals Growth

Biomea Stock prices reflect investors' perceptions of the future prospects and financial health of Biomea Fusion, and Biomea Fusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomea Stock performance.

About Biomea Fusion Performance

By analyzing Biomea Fusion's fundamental ratios, stakeholders can gain valuable insights into Biomea Fusion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomea Fusion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomea Fusion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.56)(1.64)
Return On Capital Employed(2.84)(2.70)
Return On Assets(1.56)(1.64)
Return On Equity(3.09)(2.93)

Things to note about Biomea Fusion performance evaluation

Checking the ongoing alerts about Biomea Fusion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomea Fusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Biomea Fusion is way too risky over 90 days horizon
Biomea Fusion may become a speculative penny stock
Biomea Fusion appears to be risky and price may revert if volatility continues
Biomea Fusion has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (138.43 M) with profit before overhead, payroll, taxes, and interest of 0.
Biomea Fusion currently holds about 149.63 M in cash with (119.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Biomea Fusion has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Biomea Fusion to Participate at Upcoming Investor Conferences - marketscreener.com
Evaluating Biomea Fusion's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Biomea Fusion's stock performance include:
  • Analyzing Biomea Fusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomea Fusion's stock is overvalued or undervalued compared to its peers.
  • Examining Biomea Fusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Biomea Fusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomea Fusion's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Biomea Fusion's stock. These opinions can provide insight into Biomea Fusion's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Biomea Fusion's stock performance is not an exact science, and many factors can impact Biomea Fusion's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like